Can Tan,Zhi-Dong Ge,Shreya Kurup,Yaryna Dyakiv,Ting Liu,William A Muller,Tsutomu Kume,Can TanZhi-Dong GeShreya KurupYaryna DyakivTing LiuWilliam A. MullerTsutomu KumeDepartment of Medicine,Feinberg Cardiovascular and Renal Research Institute,Feinberg School of Medicine,Northwestern University,Chicago,IL. (C.T.,S.K.,Y.D.,T.L.,T.K.)Departments of Pediatrics,Surgery,and Pathology,Cardiovascular-Thoracic Surgery and the Heart Center,Stanley Manne Children's Research Institute,Ann & Robert H. Lurie Children's Hospital of Chicago,Feinberg School of Medicine,Northwestern University,Chicago,IL. (Z.-D.G.)Department of Pathology,Feinberg School of Medicine,Northwestern University,Chicago,IL. (W.A.M.)Honors College,University of Illinois at Chicago (S.K.).

Abstract:Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print. BACKGROUND:Mitral valve (MV) disease including myxomatous degeneration is the most common form of valvular heart disease with an age-dependent frequency. Genetic evidence indicates that mutations of the transcription factorFOXC1are associated with MV defects, including MV regurgitation. In this study, we sought to determine whether murineFoxc1and its closely related factor,Foxc2, are required in valvular endothelial cells (VECs) for the maintenance of MV leaflets, including VEC junctions and the stratified trilaminar ECM (extracellular matrix).METHODS:Adult mice carrying tamoxifen-inducible, vascular endothelial cell (EC), and lymphatic EC–specific, compoundFoxc1;Foxc2mutations (ie, EC-Foxc-DKO and lymphatic EC-Foxc-DKO mice, respectively) were used to study the function ofFoxc1andFoxc2in the maintenance of MVs. The EC and lymphatic EC mutations ofFoxc1/c2were induced at 7 to 8 weeks of age by tamoxifen treatment, and abnormalities in the MVs of these mutant mice were assessed via whole-mount immunostaining, immunohistochemistry/RNAscope, Movat pentachrome/Masson Trichrome staining, and Evans blue injection.RESULTS:EC deletions ofFoxc1andFoxc2in mice resulted in abnormally extended and thicker MVs by causing defects in the regulation of ECM organization with increased proteoglycan and decreased collagen. Notably, reticular adherens junctions were found in VECs of control MV leaflets, and these reticular structures were severely disrupted in EC-Foxc-DKO mice. PROX1 (prospero homeobox protein 1), a key regulator in a subset of VECs on the fibrosa side of MVs, was downregulated in EC-Foxc1/c2mutant VECs. Furthermore, we determined the precise location of lymphatic vessels in murine MVs, and these lymphatic vessels were aberrantly expanded and dysfunctional in EC-Foxc1/c2mutant MVs. Lymphatic EC deletion ofFoxc1/c2also resulted in similar structural/ECM abnormalities as seen in EC-Foxc1/c2mutant MVs.CONCLUSIONS:Our results indicate thatFoxc1andFoxc2are required for maintaining the integrity of the MV, including VEC junctions, ECM organization, and lymphatic vessel formation/function to prevent myxomatous MV degeneration.

Prox1+ Endothelial Cells in Heart Valve Development and Homeostasis

Localized Prox1 Regulates Aortic Valve Endothelial Cell Diversity and Extracellular Matrix Stratification in Mice

PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves

Fluid-Dynamic Modeling of Flow in Embryonic Tissue Indicates That Lymphatic Valve Location Is Not Consistently Determined by the Local Fluid Shear or Its Gradient

Conditional Deletion of RB1 in the Tie2 Lineage Leads to Aortic Valve Regurgitation

FOXC1 and FOXC2 Ablation Causes Abnormal Valvular Endothelial Cell Junctions and Lymphatic Vessel Formation in Myxomatous Mitral Valve Degeneration

Understanding the cell fate and behavior of progenitors at the origin of the mouse cardiac mitral valve

RNA-Seq Analysis to Identify Novel Roles of Scleraxis during Embryonic Mouse Heart Valve Remodeling

Maturation of heart valve cell populations during postnatal remodeling

Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development

Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos

Murine aortic valve cell heterogeneity at birth

Sox7-positive endothelial progenitors establish coronary arteries and govern ventricular compaction

Scleraxis Is Required for Cell Lineage Differentiation and Extracellular Matrix Remodeling During Murine Heart Valve Formation In Vivo

Spns1-dependent endocardial lysosomal function drives valve morphogenesis through Notch1-signaling

Contractile and Hemodynamic Forces Coordinate Notch1b-mediated Outflow Tract Valve Formation

Growth and maturation of heart valves leads to changes in endothelial cell distribution, impaired function, decreased metabolism and reduced cell proliferation

APOE-NOTCH axis governs elastogenesis during human cardiac valve remodeling

Epicardial deletion of Sox9 leads to myxomatous valve degeneration and identifies Cd109 as a novel gene associated with valve development

Notch-Tnf Signalling is Required for Development and Homeostasis of Arterial Valves